Global Cardiovascular Implants Market 2015-2019 with Abbott Laboratories, Boston Scientific, Medtronic & St. Jude Medical Dominating

Dec 17, 2015, 11:10 ET from Research and Markets

DUBLIN, Dec. 17, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Cardiovascular Implants Market 2015-2019" report to their offering.

The global cardiovascular implants market to grow at a CAGR of 4.54% over the period 2014-2019.

Global Cardiovascular Implants Market 2015-2019 covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Advances in technology have led to the development of more accurate cardiovascular implant surgeries that provide better support to patients and surgeons. Vendors and research organizations are exploring different options to use intravascular robotics in a broad range of peripheral vascular procedures.

Robotics provides surgeons a better view of the operative field and the ability to maneuver instruments within close-fitting spaces with precision and control. The technology has significantly helped improve the navigation of needles, catheters, and electrode tips to specific targets during surgeries. These procedures help to reduce hospital stays and facilitate cost management. Moreover, these procedures shorten the recovery period and lessen discomfort and pain. Aware of the benefits of robot-assisted surgeries, many hospitals will install and implement such equipment during the forecast period.

Already, physicians in different universities, such as the University of Chicago and the University of Pennsylvania School of Medicine, US, are using robotic-assisted surgeries for research purposes.

According to the report, medical companies are developing many innovative cardiovascular implants to increase their revenue share. For instance, Medtronic has developed leadless pacemakers, bioabsorbable coronary scaffoldings, the CoreValve Evolut transcatheter aortic valve, and Engager transapical aortic valve. Most of these technologies are available in the US, and other developed countries such as Germany, Japan, the UK, and France. The development and introduction of innovative cardiovascular implants in the market will likely change treatment options in hospitals and increase the volume of those undergoing implantation surgeries.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • St. Jude Medical

Other prominent vendors

  • AMG International
  • Biotronik
  • B-Braun
  • Cardiac Dimension
  • Cardiac Science
  • Edwards Lifesciences
  • Fortimedix
  • Neovasc
  • On-X Life Technologies
  • Pacetronix
  • Proxy Biomedical
  • Reva Medical
  • Sorin
  • W.L. Gore & Associates

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Cardiovascular implant materials

Part 07: Cardiovascular implants regulatory classification

Part 08: Cardiovascular implants: Product recalls

Part 09: Market segmentation by product

Part 10: Average cost of cardiovascular implant surgeries

Part 11: Geographical segmentation

Part 12: Market drivers

Part 13: Impact of drivers

Part 14: Market challenges

Part 15: Impact of drivers and challenges

Part 16: Market trends

Part 17: Vendor landscape

Part 18: Key vendor analysis

Part 19: Appendix

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets